Guo Lei Feng - Net Worth and Insider Trading
Guo Lei Feng Net Worth
The estimated net worth of Guo Lei Feng is at least $5 Million dollars as of 2025-04-12. Guo Lei Feng is the Directors, Directors, and Executives of Harbin Gloria Pharmaceuticals Co Ltd and owns about 2,160,000 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) stock worth over $5 Million. Details can be seen in Guo Lei Feng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Guo Lei Feng has not made any transactions after 2017-01-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Guo Lei Feng
Guo Lei Feng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Guo Lei Feng owns 1 companies in total, including Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) .
Click here to see the complete history of Guo Lei Feng’s form 4 insider trades.
Insider Ownership Summary of Guo Lei Feng
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:002437 | Harbin Gloria Pharmaceuticals Co Ltd | 2017-01-19 | Directors & Directors & and Executives |
Guo Lei Feng Latest Holdings Summary
Guo Lei Feng currently owns a total of 1 stock. Guo Lei Feng owns 2,160,000 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) as of January 19, 2017, with a value of $5 Million.
Latest Holdings of Guo Lei Feng
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:002437 | Harbin Gloria Pharmaceuticals Co Ltd | 2017-01-19 | 2,160,000 | 2.39 | 5,162,400 |
Holding Weightings of Guo Lei Feng
Guo Lei Feng Form 4 Trading Tracker
According to the SEC Form 4 filings, Guo Lei Feng has made a total of 0 transactions in Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) over the past 5 years. The most-recent trade in Harbin Gloria Pharmaceuticals Co Ltd is the sale of 215,000 shares on January 19, 2017, which brought Guo Lei Feng around $2 Million.
Insider Trading History of Guo Lei Feng
- 1
Guo Lei Feng Trading Performance
Guo Lei Feng Ownership Network
Ownership Network List of Guo Lei Feng
Ownership Network Relation of Guo Lei Feng
Guo Lei Feng Owned Company Details
What does Harbin Gloria Pharmaceuticals Co Ltd do?
Who are the key executives at Harbin Gloria Pharmaceuticals Co Ltd?
Guo Lei Feng is the Directors & Directors & and Executives of Harbin Gloria Pharmaceuticals Co Ltd. Other key executives at Harbin Gloria Pharmaceuticals Co Ltd include Independent director Guo Yun Pei , Supervisors Wang Yu , and Directors & executives Diao Xiu Qiang .
Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) Insider Trades Summary
Over the past 18 months, Guo Lei Feng made no insider transaction in Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437). Other recent insider transactions involving Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) include a net sale of 210,000 shares made by wang dong xu ,
In summary, during the past 3 months, insiders sold 0 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 210,000 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) were sold and 0 shares were bought by its insiders, resulting in a net sale of 210,000 shares.
Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harbin Gloria Pharmaceuticals Co Ltd Insider Transactions
Guo Lei Feng Mailing Address
Above is the net worth, insider trading, and ownership report for Guo Lei Feng. Currently GuruFocus does not have mailing address information for Guo Lei Feng.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
